GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Market Cap

Shire (SHPG) Market Cap : $54,842 Mil (As of Apr. 26, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Shire Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Shire's share price for the quarter that ended in Sep. 2018 was $181.27. Shire's Shares Outstanding (EOP) for the quarter that ended in Sep. 2018 was 305 Mil. Therefore, Shire's market cap for the quarter that ended in Sep. 2018 was $55,270 Mil.

Shire's quarterly market cap increased from Mar. 2018 ($45,350 Mil) to Jun. 2018 ($51,388 Mil) and increased from Jun. 2018 ($51,388 Mil) to Sep. 2018 ($55,270 Mil).

Shire's annual market cap increased from Dec. 2015 ($40,491 Mil) to Dec. 2016 ($51,353 Mil) but then declined from Dec. 2016 ($51,353 Mil) to Dec. 2017 ($46,986 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Shire's Enterprise Value for Today is $54,842 Mil.


Shire Market Cap Historical Data

The historical data trend for Shire's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire Market Cap Chart

Shire Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27,509.16 41,693.33 40,490.78 51,352.70 46,985.85

Shire Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45,843.88 46,985.85 45,349.87 51,388.29 55,269.59

Competitive Comparison of Shire's Market Cap

For the Biotechnology subindustry, Shire's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shire's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shire's Market Cap distribution charts can be found below:

* The bar in red indicates where Shire's Market Cap falls into.



Shire Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Shire's Market Cap for the fiscal year that ended in Dec. 2017 is calculated as

Market Cap (A: Dec. 2017 )=Share Price (A: Dec. 2017 )*Shares Outstanding (EOP) (A: Dec. 2017 )
=$155.12*302.9
=$46,986

Shire's Market Cap for the quarter that ended in Sep. 2018 is calculated as

Market Cap (Q: Sep. 2018 )=Share Price (Q: Sep. 2018 )*Shares Outstanding (EOP) (Q: Sep. 2018 )
=$181.27*304.902
=$55,270

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shire  (NAS:SHPG) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Shire Market Cap Related Terms

Thank you for viewing the detailed overview of Shire's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Shire (SHPG) Business Description

Traded in Other Exchanges
N/A
Address
Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.
Executives
James H Cavanaugh director 265 HOTHORPE LANE, VILLANOVA PA 19085